Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews
SLRs are an established method for synthesizing and evaluating evidence on a particular topic. They involve a systematic and transparent process for identifying, selecting, and extracting data from relevant studies, and for synthesizing and analyzing the data to draw conclusions about the topic being studied. Data extraction is a critical step in the SLR process, but it can be a time-consuming process that is open to error when done manually, particularly for large and complex reviews.
To address these challenges, researchers are increasingly turning to AI as a tool for data extraction in SLRs. This can significantly reduce the time and effort required for data extraction and can help to minimize errors and omissions, but it is only as good as the strategies, expertise, and perspectives applied by the researcher.
This whitepaper covers 5 key dimensions of AI use, including their challenges and solutions.
Related Insights
Webinar
Use of AI to develop health economic evidence for optimized patient access
Sep 6, 2023
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Playbook
Are you using real-world evidence?
Feb 1, 2023
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Blog
Innovative modeling method could speed patient access to critical IO therapies
Jan 4, 2023
Podcast
Why Rare Disease Therapeutics Need Early Market Access Planning
Jan 4, 2023
Blog
Taking a Proactive, Preventive Approach to Data Privacy in Clinical Documentation
Sep 26, 2022
Blog
Membership in Clinical Research Data Sharing Alliance enables Parexel to shape the future of clinical trial data
Sep 7, 2022
Blog
U.S. price reforms 2022: How can drug manufacturers best prepare for the Inflation Reduction Act?
Aug 17, 2022
Blog
Preparing for a new era in European Market Access
Jul 22, 2022
Webinar
China's Market Approval Policy and Medical Insurance Payment System for Rare Disease
Jul 21, 2022
Related Insights
Webinar
Use of AI to develop health economic evidence for optimized patient access
Sep 6, 2023
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Playbook
Are you using real-world evidence?
Feb 1, 2023
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Blog
Innovative modeling method could speed patient access to critical IO therapies
Jan 4, 2023
Podcast
Why Rare Disease Therapeutics Need Early Market Access Planning
Jan 4, 2023
Blog
Taking a Proactive, Preventive Approach to Data Privacy in Clinical Documentation
Sep 26, 2022
Blog
Membership in Clinical Research Data Sharing Alliance enables Parexel to shape the future of clinical trial data
Sep 7, 2022
Blog
U.S. price reforms 2022: How can drug manufacturers best prepare for the Inflation Reduction Act?
Aug 17, 2022
Blog
Preparing for a new era in European Market Access
Jul 22, 2022
Webinar
China's Market Approval Policy and Medical Insurance Payment System for Rare Disease
Jul 21, 2022